Authors
Advertisement
Advertisement
Trending on HCPLive
1
ALOFT-IPF: Admilparant 60 mg Meets Primary FVC End Point
2
Q&A: Comorbidity Screening and Biologic Timing in HS, With Jennifer Hsiao, MD
3
GLP-1 Initiation in Heart Failure Reduces Pulmonary Artery Pressure, Hospitalizations
4
Long-Term Risankizumab Data Show Durable Crohn’s, Fistula Outcomes
5
